Literature DB >> 12010843

Airways inflammation and COPD: epithelial-neutrophil interactions.

Carol A Pettersen1, Kenneth B Adler.   

Abstract

Neutrophils are recognized as major cellular mediators of inflammation. They contain specific and highly regulated mechanisms for controlling the expression of adhesion molecules that allow for their tethering and migration into inflammatory sites. These adhesion molecules not only are activated by exogenous pollutants but are regulated by endothelial and epithelial cell signals. Lipid mediators, such as platelet-activating factor, reactive oxygen and nitrogen species, and cytokines from airway epithelial cells, further control neutrophil functions such as infiltration and activation resulting in an increase in respiratory burst activity and release of granule enzymes, such as elastase. Furthermore, virus and bacteria products affect inflammation by increasing secondary epithelial mediators. However, once the endogenous or exogenous agents are expelled, neutrophil populations are programmed to die and are cleared by macrophage phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010843     DOI: 10.1378/chest.121.5_suppl.142s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  Interleukin-15 increases neutrophil adhesion onto human respiratory epithelial A549 cells and attracts neutrophils in vivo.

Authors:  M Pelletier; D Girard
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Glutathione s-transferases M1 and P1 prevent aggravation of allergic responses by secondhand smoke.

Authors:  Frank D Gilliland; Yu-Fen Li; Henry Gong; David Diaz-Sanchez
Journal:  Am J Respir Crit Care Med       Date:  2006-10-05       Impact factor: 21.405

3.  Fibroblast growth factor 10 protects against particulate matter-induced airway inflammatory response through regulating inflammatory signaling and apoptosis.

Authors:  Lingjing Liu; Ziqiang Xia; Jingli Li; Yiran Hu; Qiang Wang; Junjie Chen; Shiqian Fan; Jinming Wu; Nian Dong; Chengshui Chen
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

4.  Alpha-4/beta-1 and alpha-L/beta-2 integrins mediate cytokine induced lung leukocyte-epithelial adhesion and injury.

Authors:  L A Parmley; N D Elkins; M A Fini; Y-E Liu; J E Repine; R M Wright
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

5.  [18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation.

Authors:  Delphine L Chen; Timothy J Bedient; James Kozlowski; Daniel B Rosenbluth; Warren Isakow; Thomas W Ferkol; Betsy Thomas; Mark A Mintun; Daniel P Schuster; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2009-07-02       Impact factor: 21.405

Review 6.  Protease-activated receptors and prostaglandins in inflammatory lung disease.

Authors:  Terence Peters; Peter J Henry
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

7.  Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells.

Authors:  Elisabetta Pace; Maria Ferraro; Liboria Siena; Mario Melis; Angela M Montalbano; Malcolm Johnson; Maria R Bonsignore; Giovanni Bonsignore; Mark Gjomarkaj
Journal:  Immunology       Date:  2008-01-22       Impact factor: 7.397

8.  Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains.

Authors:  Wondwossen Abate; Abdulaziz A Alghaithy; Joan Parton; Kenneth P Jones; Simon K Jackson
Journal:  J Lipid Res       Date:  2009-08-01       Impact factor: 5.922

9.  Effects of inhaled thrombin receptor agonists in mice.

Authors:  James D Moffatt; Rebecca Lever; Clive P Page
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

10.  Determinants of cardiac troponin T elevation in COPD exacerbation - a cross-sectional study.

Authors:  Pål H Brekke; Torbjørn Omland; Stein Harald Holmedal; Pål Smith; Vidar Søyseth
Journal:  BMC Pulm Med       Date:  2009-07-19       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.